In a recent study posted to bioRxiv*, researchers performed an analysis of molecular variance (AMOVA) in 59 haplotypes of the interferon (IFN)-alpha (α) /beta (β) receptor (IFNAR) gene, departing from ...

Gemcitabine (GEM) (day 1–8) plus carboplatin (CBDCA) (day 2) for the treatment of advanced non-small cell lung cancer (aNSCLC) in elderly or poor performance status (PS) patients (pts) No significant ...

Individuals with some forms of heart failure are treated with drugs that are known as beta-blockers because they target proteins known as beta-adrenergic receptors (beta-ARs). Now, a potential ...

The addition of β-adrenergic antagonists to the treatment regimen for heart failure has validated the neurohormonal hypothesis and provided much-improved outcomes. This benefit had been in question ...

Please provide your email address to receive an email when new articles are posted on . “COVID-19 results in a significant increase in new-onset diabetes,” Irl Hirsch, MD, an endocrinologist and ...

Medically reviewed by Jeffrey S. Lander, MD Many medications can help lower high blood pressure (hypertension), but no single one works best for everyone. The good news is, with some patience and help ...

If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between them, ultimately destroying the neural networks that underlie our memories ...

Updated clinical data from the Phase 1/2 ABILITY-1 Study evaluating MDNA11, an emerging best-in-class IL-2 therapy, as a monotherapy and in combination with pembrolizumab, will be presented by Dr.

Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...